Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Challenging the dogma of high target doses in the treatment of heart failure: is more always better?

Follath F.

Arch Cardiovasc Dis. 2009 Nov;102(11):785-9. doi: 10.1016/j.acvd.2009.08.011. Epub 2009 Nov 13. Review.

3.

A review of heart failure management in the elderly population.

Cheng JW, Nayar M.

Am J Geriatr Pharmacother. 2009 Oct;7(5):233-49. doi: 10.1016/j.amjopharm.2009.10.001. Review.

PMID:
19948300
5.

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators.

Am J Cardiovasc Drugs. 2007;7(5):373-80.

PMID:
18041162
6.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
7.

Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.

Lenzen MJ, Boersma E, Reimer WJ, Balk AH, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JG.

Eur Heart J. 2005 Dec;26(24):2706-13. Epub 2005 Sep 23.

PMID:
16183692
8.
9.

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.

McMurray J, Cohen-Solal A, Dietz R, Eichhorn E, Erhardt L, Hobbs FD, Krum H, Maggioni A, McKelvie RS, Piña IL, Soler-Soler J, Swedberg K.

Eur J Heart Fail. 2005 Aug;7(5):710-21.

10.

Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.

Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Circ Heart Fail. 2010 Sep;3(5):596-605. doi: 10.1161/CIRCHEARTFAILURE.109.912683. Epub 2010 Jul 15.

11.

Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians.

Remme WJ, McMurray JJ, Hobbs FD, Cohen-Solal A, Lopez-Sendon J, Boccanelli A, Zannad F, Rauch B, Keukelaar K, Macarie C, Ruzyllo W, Cline C; SHAPE Study Group.

Eur Heart J. 2008 Jul;29(14):1739-52. doi: 10.1093/eurheartj/ehn196. Epub 2008 May 27.

PMID:
18506054
12.

Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.

Levy E, Levy P.

Pharmacoeconomics. 2002;20(14):963-77. Review.

PMID:
12403637
13.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program.

Can J Cardiol. 2004 Jan;20(1):41-54.

PMID:
14968142
14.

Digoxin remains useful in the management of chronic heart failure.

Dec GW.

Med Clin North Am. 2003 Mar;87(2):317-37. Review.

PMID:
12693728
15.
16.

Undertreatment of congestive heart failure in an Australian setting.

Boyles PJ, Peterson GM, Bleasel MD, Vial JH.

J Clin Pharm Ther. 2004 Feb;29(1):15-22.

PMID:
14748893
17.

Euro heart failure survey. Medical treatment not in line with current guidelines.

Drechsler K, Dietz R, Klein H, Wollert KC, Storp D, Molling J, Zeymer U, Niebauer J.

Z Kardiol. 2005 Aug;94(8):510-5.

PMID:
16049652
18.

Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy.

Peters-Klimm F, Müller-Tasch T, Schellberg D, Remppis A, Barth A, Holzapfel N, Jünger J, Herzog W, Szecsenyi J.

Clin Res Cardiol. 2008 Apr;97(4):244-52. Epub 2007 Nov 28.

PMID:
18046524
19.

Optimising the use of beta-blockers in older patients with heart failure.

Owen A.

Drugs Aging. 2002;19(9):671-84. Review.

PMID:
12381236
20.

[Addition of beta blockers in chronic heart failure].

Missault LH, van Veldhuisen DJ.

Ned Tijdschr Geneeskd. 2000 Sep 30;144(40):1905-10. Review. Dutch.

PMID:
11045137

Supplemental Content

Support Center